The company has an authorized capital of 10,000,000 shares of Indonesia Rupiah 1,000 per share aggregating to Ten billion Rupiah
The new plant will be dedicated to the manufacturing of a broad range of waterproofing and construction chemicals solutions, as well as 3D printing solutions to support the Group’s pioneer positioning in this new market segment
NATCO and Arrow shall launch the product on agreed-upon launch dates in the future.
The company reported total income of Rs.1475.59 crores during the 12 months period ended March 31, 2021
PPG expects that all conditions to the completion of the tender offer will be fulfilled at the tender offer expiration date of June 4, 2021.
The company launched and expanded sales of acrylic rubber and non-phthalate allyl resins
Q4 FY21 revenues reached Rs. 1,469 crore, up by 39% Y-o-Y whereas Profit After Tax at Rs. 290 crore, rose 68% on a Y-o-Y basis
Company is investing 117 million euros to strengthen its global leadership in the manufacture of LAB, which will enable it to increase production to meet the growing demand generated by the COVID-19 pandemic
First batch produced at Panacea Biotec’s facilities at Baddi will be shipped to the Gamaleya Center for quality control and full scale production of the vaccine is due to start this summer
We focused on developing the product last year but now our focus is on ramping up our manufacturing capacity
NATCO Pharmaceuticals, Hyderabad; Alembic Pharmaceuticals, Vadodara; Gufic Biosciences Ltd., Gujarat; Emcure Pharmaceuticals, Pune; and Lyka, Gujarat are new manufacturers
The company reported total income of Rs.455.28 crores during the 12 months period ended March 31, 2021
The product patent has been already filed under fast track approval
Allecra Therapeutics would now either directly or through out license file for NDA of this molecule.
The ethanol business has become a feather on the cap of Company's performance in the Distillery segment
Akzo Nobel India has reported total income of Rs.2444.60 crores during FY 2020-21
Drop in revenue in the fourth quarter is normal as China is shut down for most of the quarter due to the Chinese New Year holiday
The transaction, which is subject to customary closing conditions and regulatory approvals, is expected to close in 2022
The advanced materials business recorded 1 trillion 41.4 billion KRW in revenue and 115.7 billion KRW in operating profits
Availability of drugs is being monitored by implementing a three-pronged strategy of supply chain management, demand side management, and affordability.
Subscribe To Our Newsletter & Stay Updated
_280_300.jpg)
